Inflammaging Beyond Biomarkers: Molecular Mechanisms And Therapeutic Opportunities
As we age, our bodies often experience a persistent, low-level inflammation, a phenomenon scientists call “inflammaging.” Unlike the acute inflammation that helps us heal from an injury, this chronic, subtle inflammation doesn’t go away and is increasingly recognized as a major contributor to many age-related conditions, from heart disease to neurodegeneration.
Traditionally, doctors might look at general inflammatory markers in the blood to gauge inflammation. However, recent research suggests these markers alone don’t fully capture the complex, tissue-specific nature of inflammaging or its underlying causes. Instead, the focus is shifting to understanding the specific molecular processes that fuel this age-related inflammation.
Several key mechanisms are at play. For instance, as cells age, some enter a state called “cellular senescence,” where they stop dividing but remain active, releasing a cocktail of inflammatory molecules known as the “senescence-associated secretory phenotype” (SASP). Think of them as “zombie cells” that refuse to die and instead spread trouble. Additionally, the “powerhouses” of our cells, mitochondria, can become dysfunctional, releasing “danger signals” (damage-associated molecular patterns or DAMPs) that trigger immune responses. Changes in our gut bacteria and the way our immune system functions with age also contribute to this inflammatory environment.
At a deeper level, specific cellular pathways, like NF-κB and the NLRP3 inflammasome, act as central control hubs, integrating various signals to sustain this chronic inflammation. By understanding these intricate molecular mechanisms, scientists are opening doors to new therapeutic strategies. Instead of just broadly suppressing inflammation, future treatments could involve targeting these specific pathways, removing senescent cells with “senolytics,” or using molecules that actively help resolve inflammation. This shift in understanding offers promising avenues for promoting healthier aging.
Source: link to paper